Skip to main navigation
Skip to search
Skip to main content
Princeton University Home
Help & FAQ
Home
Profiles
Research units
Facilities
Projects
Research output
Press/Media
Search by expertise, name or affiliation
Multidrug- and carbapenem-resistant Pseudomonas aeruginosa in Children, United States, 1999-2012
for the Prevention Epicenters Program, US Centers for Disease Control and Prevention
Princeton School of Public and International Affairs
High Meadows Environmental Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
81
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Multidrug- and carbapenem-resistant Pseudomonas aeruginosa in Children, United States, 1999-2012'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Pseudomonas aeruginosa
100%
Carbapenem
100%
Antiinfective Agent
16%
Antibiotics
8%
Infection
8%
Prevalence
8%
Cystic Fibrosis
8%
Aminoglycoside
8%
Quinolone Derivative
8%
Antimicrobial Resistance
8%
Cephalosporin Derivative
8%
Healthcare Associated Infection
8%
Piperacillin Plus Tazobactam
8%
Keyphrases
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
100%
Pediatric Setting
10%
Reference Laboratory
10%
North Central Region
10%
Intensive Care Setting
10%
Respiratory Specimens
10%
Agricultural and Biological Sciences
Piperacillin/Tazobactam
8%
Prevention Strategies
8%
Aminoglycoside
8%